Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 529 - 536 of 11439 results
ITC Blocks Imports Of TVs For Infringing AMD Patent
January 25, 2024| News
Health Care Privacy and Security in 2024: Six Critical Topics to Watch
January 25, 2024| Blog| Viewpoint
50 Women to Watch: Jennifer Rubin
January 24, 2024| News
How Compulsory Licenses Can Affect Domestic and Foreign Prosecution
January 24, 2024| Blog| Viewpoint
Update: USCIS Poised to Increase Immigration Filing Fees
January 24, 2024| Alert| Viewpoint
Algorithmic Disgorgement: An Increasingly Important Part of the FTC’s Remedial Arsenal— AI: The Washington Report
January 24, 2024| Article| Viewpoint
New York Court Puts Breaks on Manual Worker Weekly Wage Payment Claims
January 23, 2024| Blog| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.